Skip to main content

Table 2 Adjusted risk of longer duration of MODS in entire cohort and those with septic shock

From: Hydrocortisone treatment is associated with a longer duration of MODS in pediatric patients with severe sepsis and immunoparalysis

Variable

Entire cohort

Septic shock subset

aRR

Lower CL

Upper CL

p-value

aRR

Lower CL

Upper CL

p value

Baseline immune compromise

0.95

0.49

1.85

0.891

0.56

0.28

1.14

0.1117

CCC

1.97

1.22

3.19

0.0054

1.73

1.09

2.76

0.0198

VIS

1.01

1.00

1.03

0.0166

1.01

1.00

1.02

0.1236

RBC Transfusion

1.83

1.18

2.83

0.0066

1.47

0.94

2.28

0.0882

Hydrocortisone

1.79

1.06

3.04

0.0295

2.74

1.60

4.70

0.0002

  1. CCC complex chronic condition, VIS Vasoactive Inotrope Score, RBC red blood cell
Back to article page

Critical Care

ISSN: 1364-8535